[go: up one dir, main page]

NO952713L - Fremgangsmåte for fremstilling av substituerte indolonderivater - Google Patents

Fremgangsmåte for fremstilling av substituerte indolonderivater

Info

Publication number
NO952713L
NO952713L NO952713A NO952713A NO952713L NO 952713 L NO952713 L NO 952713L NO 952713 A NO952713 A NO 952713A NO 952713 A NO952713 A NO 952713A NO 952713 L NO952713 L NO 952713L
Authority
NO
Norway
Prior art keywords
preparation
indolone derivatives
substituted indolone
substituted
derivatives
Prior art date
Application number
NO952713A
Other languages
English (en)
Other versions
NO952713D0 (no
NO305363B1 (no
Inventor
Andrew S Wells
Norman John Lewis
Timothy Charles Walsgrove
Paul Oxley
Joseph Marian Fortunak
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of NO952713D0 publication Critical patent/NO952713D0/no
Publication of NO952713L publication Critical patent/NO952713L/no
Publication of NO305363B1 publication Critical patent/NO305363B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO952713A 1993-01-08 1995-07-07 FremgangsmÕte for fremstilling av substituerte indolonderivater og forbindelsene derav NO305363B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939300309A GB9300309D0 (en) 1993-01-08 1993-01-08 Process
PCT/EP1993/003706 WO1994015918A1 (en) 1993-01-08 1993-12-27 Process for the preparation of substituted indolone derivatives

Publications (3)

Publication Number Publication Date
NO952713D0 NO952713D0 (no) 1995-07-07
NO952713L true NO952713L (no) 1995-07-07
NO305363B1 NO305363B1 (no) 1999-05-18

Family

ID=10728465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952713A NO305363B1 (no) 1993-01-08 1995-07-07 FremgangsmÕte for fremstilling av substituerte indolonderivater og forbindelsene derav

Country Status (7)

Country Link
FI (1) FI114094B (no)
GB (1) GB9300309D0 (no)
HU (1) HUT72075A (no)
MA (1) MA23081A1 (no)
NO (1) NO305363B1 (no)
PL (1) PL176152B1 (no)
WO (1) WO1994015918A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237307B1 (es) * 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
WO2008075169A2 (en) * 2006-12-15 2008-06-26 Orchid Chemicals & Pharmaceuticals Limited A process for the purification of ropinirole hydrochloride
WO2011030330A2 (en) * 2009-09-09 2011-03-17 Taro Pharmaceutical Industries Ltd. Process for the purification of ropinirole hydrochloride
US10961194B2 (en) 2017-06-16 2021-03-30 Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. Method for purifying ropinirole hydrochloride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882236A (en) * 1973-12-26 1975-05-06 Lilly Co Eli Pharmaceutical compositions containing substituted 2-oxo-indolines and the use thereof to treat anxiety and tension
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593106A (en) * 1984-06-04 1986-06-03 Smithkline Beckman Corporation 4-[2-(dialkylamino)ethyl]-7-hydroxyisatins
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
PL309645A1 (en) 1995-10-30
FI953361A0 (fi) 1995-07-07
NO952713D0 (no) 1995-07-07
GB9300309D0 (en) 1993-03-03
WO1994015918A1 (en) 1994-07-21
MA23081A1 (fr) 1994-10-01
HUT72075A (en) 1996-03-28
NO305363B1 (no) 1999-05-18
FI114094B (fi) 2004-08-13
FI953361L (fi) 1995-07-07
PL176152B1 (pl) 1999-04-30

Similar Documents

Publication Publication Date Title
NO981432D0 (no) Fremgangsmåte for fremstilling av piperidinderivater
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO941659D0 (no) Fremgangsmåte for fremstilling av aluminoksaner
NO952713D0 (no) Fremgangsmåte for fremstilling av substituerte indolonderivater
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
NO179866C (no) Fremgangsmåte for fremstilling av indoler
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin
FI953617L (fi) Menetelmä substituoitujen 4-hydroksikumariinien valmistamiseksi
FI951047A0 (fi) Menetelmä indolijohdannaisten valmistamiseksi
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO963084D0 (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
NO991098L (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
NO943237D0 (no) Fremgangsmåte for fremstilling av benzotiazepinderivater
NO177305C (no) Fremgangsmåte for fremstilling av 3-substituerte-2-oksindol-derivater
NO180301C (no) Fremgangsmåte for fremstilling av azaspiroalkanderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees